Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 4 JUN 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Sickinger MT, von Tresckow B, Kobe C, Engert A, Skoetz N. Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010533. DOI: 10.1002/14651858.CD010533.
- Publication Status: New
- Published Online: 4 JUN 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of interim [18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) imaging for treatment modification in patients with Hodgkin lymphoma by critical, systematic and statistical analysis of randomised controlled trials, regarding overall survival, progression-free survival, response rate, adverse events and quality of life.